2022-09-22 |
2022-09-21 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
607 497
-6.7%
18,54
11 262 994
USD
|
607 497
-6.7%
|
18,54
|
11 262 994
USD
|
|
2022-09-20 |
2022-09-20 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
2 266
-0.0%
20,10
45 547
USD
|
2 266
-0.0%
|
20,10
|
45 547
USD
|
|
2022-09-20 |
2022-09-20 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
146 404
-1.6%
19,50
2 854 878
USD
|
146 404
-1.6%
|
19,50
|
2 854 878
USD
|
|
2022-09-20 |
2022-09-20 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
2 266
-0.0%
20,10
45 547
USD
|
2 266
-0.0%
|
20,10
|
45 547
USD
|
|
2022-09-20 |
2022-09-20 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
146 404
-1.6%
19,50
2 854 878
USD
|
146 404
-1.6%
|
19,50
|
2 854 878
USD
|
|
2022-09-20 |
2022-09-19 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
76 725
-0.8%
20,57
1 578 233
USD
|
76 725
-0.8%
|
20,57
|
1 578 233
USD
|
|
2022-09-20 |
2022-09-19 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
76 725
-0.8%
20,57
1 578 233
USD
|
76 725
-0.8%
|
20,57
|
1 578 233
USD
|
|
2022-09-20 |
2022-09-16 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
3 722
-0.0%
22,04
82 033
USD
|
3 722
-0.0%
|
22,04
|
82 033
USD
|
|
2022-09-20 |
2022-09-16 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
111 585
-1.2%
21,53
2 402 425
USD
|
111 585
-1.2%
|
21,53
|
2 402 425
USD
|
|
2022-09-20 |
2022-09-16 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
3 722
-0.0%
22,04
82 033
USD
|
3 722
-0.0%
|
22,04
|
82 033
USD
|
|
2022-09-20 |
2022-09-16 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
111 585
-1.2%
21,53
2 402 425
USD
|
111 585
-1.2%
|
21,53
|
2 402 425
USD
|
|
2022-09-15 |
2022-09-15 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
3 314
-0.0%
23,73
78 641
USD
|
3 314
-0.0%
|
23,73
|
78 641
USD
|
|
2022-09-15 |
2022-09-15 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
47 967
-0.5%
22,79
1 093 168
USD
|
47 967
-0.5%
|
22,79
|
1 093 168
USD
|
|
2022-09-15 |
2022-09-15 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
3 314
-0.0%
23,73
78 641
USD
|
3 314
-0.0%
|
23,73
|
78 641
USD
|
|
2022-09-15 |
2022-09-15 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
47 967
-0.5%
22,79
1 093 168
USD
|
47 967
-0.5%
|
22,79
|
1 093 168
USD
|
|
2022-09-15 |
2022-09-14 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
384
-0.0%
24,29
9 327
USD
|
384
-0.0%
|
24,29
|
9 327
USD
|
|
2022-09-15 |
2022-09-14 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
105 727
-1.1%
23,68
2 503 615
USD
|
105 727
-1.1%
|
23,68
|
2 503 615
USD
|
|
2022-09-15 |
2022-09-14 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
384
-0.0%
24,29
9 327
USD
|
384
-0.0%
|
24,29
|
9 327
USD
|
|
2022-09-15 |
2022-09-14 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
105 727
-1.1%
23,68
2 503 615
USD
|
105 727
-1.1%
|
23,68
|
2 503 615
USD
|
|
2022-09-15 |
2022-09-13 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
1 003
-0.0%
25,01
25 085
USD
|
1 003
-0.0%
|
25,01
|
25 085
USD
|
|
2022-09-15 |
2022-09-13 |
V
Vente
|
Grant Julie Papanek
Administrateur non-exécutif
|
86 644
-0.9%
24,39
2 113 247
USD
|
86 644
-0.9%
|
24,39
|
2 113 247
USD
|
|
2022-09-15 |
2022-09-13 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
1 003
-0.0%
25,01
25 085
USD
|
1 003
-0.0%
|
25,01
|
25 085
USD
|
|
2022-09-15 |
2022-09-13 |
V
Vente
|
Canaan XI L.P.
Large shareholder
|
86 644
-0.9%
24,39
2 113 247
USD
|
86 644
-0.9%
|
24,39
|
2 113 247
USD
|
|
2022-09-15 |
2022-09-02 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
5 000
-1.1%
23,82
119 108
USD
|
5 000
-1.1%
|
23,82
|
119 108
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
1 394
-0.4%
23,80
33 175
USD
|
1 394
-0.4%
|
23,80
|
33 175
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
8 606
-2.7%
23,16
199 309
USD
|
8 606
-2.7%
|
23,16
|
199 309
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
1 859
-0.1%
23,79
44 227
USD
|
1 859
-0.1%
|
23,79
|
44 227
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
10 641
-0.8%
23,15
246 354
USD
|
10 641
-0.8%
|
23,15
|
246 354
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
1 859
-0.1%
23,79
44 227
USD
|
1 859
-0.1%
|
23,79
|
44 227
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
10 641
-0.8%
23,15
246 354
USD
|
10 641
-0.8%
|
23,15
|
246 354
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
531
-0.1%
23,80
12 636
USD
|
531
-0.1%
|
23,80
|
12 636
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
4 469
-1.0%
23,21
103 723
USD
|
4 469
-1.0%
|
23,21
|
103 723
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
1 589
-0.1%
23,79
37 808
USD
|
1 589
-0.1%
|
23,79
|
37 808
USD
|
|
2022-09-06 |
2022-09-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
8 411
-0.6%
23,14
194 643
USD
|
8 411
-0.6%
|
23,14
|
194 643
USD
|
|
2022-08-17 |
2022-08-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
4 003
-0.3%
24,31
97 313
USD
|
4 003
-0.3%
|
24,31
|
97 313
USD
|
|
2022-08-17 |
2022-08-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
1 089
-0.3%
24,31
26 474
USD
|
1 089
-0.3%
|
24,31
|
26 474
USD
|
|
2022-08-17 |
2022-08-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
941
-0.1%
24,31
22 876
USD
|
941
-0.1%
|
24,31
|
22 876
USD
|
|
2022-08-08 |
2022-08-05 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
5 000
-1.1%
20,00
100 000
USD
|
5 000
-1.1%
|
20,00
|
100 000
USD
|
|
2022-08-08 |
2022-08-04 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
5 000
-1.1%
20,00
100 004
USD
|
5 000
-1.1%
|
20,00
|
100 004
USD
|
|
2022-08-05 |
2022-08-04 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
20,00
250 021
USD
|
12 500
-1.0%
|
20,00
|
250 021
USD
|
|
2022-08-05 |
2022-08-04 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.0%
20,05
200 541
USD
|
10 000
-3.0%
|
20,05
|
200 541
USD
|
|
2022-08-03 |
2022-08-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
16,88
168 810
USD
|
10 000
-0.8%
|
16,88
|
168 810
USD
|
|
2022-07-20 |
2022-07-18 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
2 600
-0.2%
20,00
52 003
USD
|
2 600
-0.2%
|
20,00
|
52 003
USD
|
|
2022-07-20 |
2022-07-18 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
2 600
-0.6%
20,00
52 001
USD
|
2 600
-0.6%
|
20,00
|
52 001
USD
|
|
2022-07-20 |
2022-07-18 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
2 500
-0.7%
20,00
50 000
USD
|
2 500
-0.7%
|
20,00
|
50 000
USD
|
|
2022-07-12 |
2022-07-08 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
1 795
-0.1%
20,00
35 900
USD
|
1 795
-0.1%
|
20,00
|
35 900
USD
|
|
2022-07-12 |
2022-07-08 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
1 242
-0.3%
20,00
24 840
USD
|
1 242
-0.3%
|
20,00
|
24 840
USD
|
|
2022-07-12 |
2022-07-08 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
1 416
-0.4%
20,00
28 320
USD
|
1 416
-0.4%
|
20,00
|
28 320
USD
|
|
2022-07-06 |
2022-07-05 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
800
-0.2%
20,00
16 000
USD
|
800
-0.2%
|
20,00
|
16 000
USD
|
|
2022-07-06 |
2022-07-05 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
800
-0.2%
20,00
16 000
USD
|
800
-0.2%
|
20,00
|
16 000
USD
|
|
2022-07-06 |
2022-07-05 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
857
-0.1%
20,00
17 140
USD
|
857
-0.1%
|
20,00
|
17 140
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
867
-0.1%
19,95
17 296
USD
|
867
-0.1%
|
19,95
|
17 296
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
3 309
-0.3%
19,23
63 625
USD
|
3 309
-0.3%
|
19,23
|
63 625
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
5 824
-0.4%
18,24
106 237
USD
|
5 824
-0.4%
|
18,24
|
106 237
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
1 479
-0.4%
20,00
29 580
USD
|
1 479
-0.4%
|
20,00
|
29 580
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
Grant Papanek Julie
Administrateur non-exécutif
|
1 000
-0.2%
20,00
20 000
USD
|
1 000
-0.2%
|
20,00
|
20 000
USD
|
|
2022-07-06 |
2022-07-01 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
1 746
-0.1%
20,00
34 920
USD
|
1 746
-0.1%
|
20,00
|
34 920
USD
|
|
2022-06-22 |
2022-06-17 |
A
Achat
|
Atlas Venture Opportunity Fund II, L.P.
Large shareholder
|
766 667
+inf%
15,00
11 500 005
USD
|
766 667
+inf%
|
15,00
|
11 500 005
USD
|
|
2022-06-22 |
2022-06-17 |
A
Achat
|
Gladstone Michael
Administrateur non-exécutif
|
766 667
+inf%
15,00
11 500 005
USD
|
766 667
+inf%
|
15,00
|
11 500 005
USD
|
|
2022-06-21 |
2022-06-17 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
1 200 000
+12.7%
15,00
18 000 000
USD
|
1 200 000
+12.7%
|
15,00
|
18 000 000
USD
|
|
2022-06-17 |
2022-06-15 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
50 000
-3.7%
16,26
813 155
USD
|
50 000
-3.7%
|
16,26
|
813 155
USD
|
|
2022-01-20 |
2022-01-20 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
4 615
+0.0%
14,73
67 976
USD
|
4 615
+0.0%
|
14,73
|
67 976
USD
|
|
2022-01-20 |
2022-01-19 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
58 818
+0.6%
14,70
864 566
USD
|
58 818
+0.6%
|
14,70
|
864 566
USD
|
|
2022-01-20 |
2022-01-18 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Large shareholder
|
43 429
+0.5%
14,26
619 367
USD
|
43 429
+0.5%
|
14,26
|
619 367
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
3 328
-0.2%
17,41
57 944
USD
|
3 328
-0.2%
|
17,41
|
57 944
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
6 672
-0.5%
16,95
113 074
USD
|
6 672
-0.5%
|
16,95
|
113 074
USD
|
|
2021-12-09 |
2021-12-08 |
V
Vente
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
110 338
-1.8%
18,03
1 989 394
USD
|
110 338
-1.8%
|
18,03
|
1 989 394
USD
|
|
2021-12-09 |
2021-12-07 |
V
Vente
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
58 190
-0.9%
19,50
1 134 705
USD
|
58 190
-0.9%
|
19,50
|
1 134 705
USD
|
|
2021-12-09 |
2021-12-07 |
V
Vente
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
128 745
-2.0%
18,43
2 372 770
USD
|
128 745
-2.0%
|
18,43
|
2 372 770
USD
|
|
2021-12-07 |
2021-12-06 |
V
Vente
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
97 692
-1.5%
18,05
1 763 341
USD
|
97 692
-1.5%
|
18,05
|
1 763 341
USD
|
|
2021-12-07 |
2021-12-03 |
V
Vente
|
TAKEDA PHARMACEUTICAL CO LTD
Large shareholder
|
12 517
-0.2%
18,47
231 189
USD
|
12 517
-0.2%
|
18,47
|
231 189
USD
|
|
2021-12-03 |
2021-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
409
-0.0%
18,24
7 462
USD
|
409
-0.0%
|
18,24
|
7 462
USD
|
|
2021-12-03 |
2021-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
4 502
-0.3%
17,81
80 189
USD
|
4 502
-0.3%
|
17,81
|
80 189
USD
|
|
2021-12-03 |
2021-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
5 089
-0.4%
16,62
84 591
USD
|
5 089
-0.4%
|
16,62
|
84 591
USD
|
|
2021-06-03 |
2021-06-01 |
A
Achat
|
AI Day 1 LLC
Affiliate of 10% Owner
Large shareholder
|
875 000
+10.3%
16,00
14 000 000
USD
|
875 000
+10.3%
|
16,00
|
14 000 000
USD
|
|